TENISUG-M 1000
| Brand | TENISUG-M 1000 |
|---|---|
| Composition | Teneligliptin 20mg + Metformin Hydrochloride 1000mg (Prolonged Release) |
| Packing | 10X10 |
| Pack Type | Tab |
For pharmaceutical trade buyers, not patient or consumer sales. This record reproduces company product information, not medical advice. Current product availability and terms are confirmed by Intra Life.
Enquire about TENISUG-M 1000Indication listed by Intra Life
For management of type 2 diabetes mellitus, alongside diet and exercise, to improve blood glucose control.
Mechanism of action
Teneligliptin inhibits DPP-4, increasing active incretin hormones. This supports glucose-dependent insulin release and reduces glucagon release. Metformin reduces glucose production in the liver and improves insulin sensitivity.
Company-listed product information for pharmaceutical trade reference, not personal medical advice. Dosage, patient suitability and treatment decisions must follow the current approved pack insert and a registered medical practitioner.
TENISUG-M 1000 for B2B enquiries
Distributors, stockists, medical stores, hospitals and PCD franchise buyers can share their city, quantity and product requirements. Ask the team for current supply, packing and trade terms.
Ask for trade details on WhatsAppKeep exploring
Browse related brand searches · All published products · Browse divisions
Explore products with a matching ingredient term
For catalogue browsing only, not substitutions. Formulations and strengths differ.
TENISUG-PG
TENISUG-PM TABS
TENISUG-20
TENIFIX-20